المؤلفون: Rimini, Margherita, Macarulla, Teresa, Burgio, Valentina, Lonardi, Sara, Niger, Monica, Scartozzi, Mario, Rapposelli, Ilario G, Aprile, Giuseppe, Ratti, Francesca, Pedica, Federica, Verdaguer, Helena, Nappo, Floriana, Nichetti, Federico, Lai, Eleonora, Valgiusti, Martina, Cappetta, Alessandro, Febregat, Carles, Fassan, Matteo, De Braud, Filippo, Puzzoni, Marco, Frassineti, Giovanni L, Simionato, Francesca, De Cobelli, Francesco, Aldrighetti, Luca, Fornaro, Lorenzo, Cascinu, Stefano, Casadei-Gardini, Andrea

المساهمون: Rimini, Margherita, Macarulla, Teresa, Burgio, Valentina, Lonardi, Sara, Niger, Monica, Scartozzi, Mario, Rapposelli, Ilario G, Aprile, Giuseppe, Ratti, Francesca, Pedica, Federica, Verdaguer, Helena, Nappo, Floriana, Nichetti, Federico, Lai, Eleonora, Valgiusti, Martina, Cappetta, Alessandro, Febregat, Carle, Fassan, Matteo, De Braud, Filippo, Puzzoni, Marco, Frassineti, Giovanni L, Simionato, Francesca, De Cobelli, Francesco, Aldrighetti, Luca, Fornaro, Lorenzo, Cascinu, Stefano, Casadei-Gardini, Andrea

مصطلحات موضوعية: BRCAness phenotype, Biliary tract cancer, PARP inhibitors, Platinum-based chemotherapy, Antineoplastic Agents, Bile Ducts, Intrahepatic, Humans, Mutation, Prognosis, Bile Duct Neoplasms, Cholangiocarcinoma, Genetic Profile, Organoplatinum Compounds

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/35749808; info:eu-repo/semantics/altIdentifier/wos/WOS:000823826500323; volume:171; firstpage:232; lastpage:241; numberofpages:10; journal:EUROPEAN JOURNAL OF CANCER; http://hdl.handle.net/20.500.11768/132357Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85132708031

الإتاحة: https://doi.org/20.500.11768/132357Test
https://doi.org/10.1016/j.ejca.2022.05.004Test
https://hdl.handle.net/20.500.11768/132357Test

المؤلفون: Margherita Rimini, Teresa Macarulla, Valentina Burgio, Sara Lonardi, Monica Niger, Mario Scartozzi, Ilario G. Rapposelli, Giuseppe Aprile, Francesca Ratti, Federica Pedica, Helena Verdaguer, Floriana Nappo, Federico Nichetti, Eleonora Lai, Martina Valgiusti, Alessandro Cappetta, Carles Fabregat-Franco, Matteo Fassan, Filippo De Braud, Marco Puzzoni, Giovanni L. Frassineti, Francesca Simionato, Francesco De Cobelli, Luca Aldrighetti, Lorenzo Fornaro, Stefano Cascinu, Andrea Casadei-Gardini

المساهمون: Rimini, Margherita, Macarulla, Teresa, Burgio, Valentina, Lonardi, Sara, Niger, Monica, Scartozzi, Mario, Rapposelli, Ilario G, Aprile, Giuseppe, Ratti, Francesca, Pedica, Federica, Verdaguer, Helena, Nappo, Floriana, Nichetti, Federico, Lai, Eleonora, Valgiusti, Martina, Cappetta, Alessandro, Febregat, Carle, Fassan, Matteo, De Braud, Filippo, Puzzoni, Marco, Frassineti, Giovanni L, Simionato, Francesca, De Cobelli, Francesco, Aldrighetti, Luca, Fornaro, Lorenzo, Cascinu, Stefano, Casadei-Gardini, Andrea

المصدر: European Journal of Cancer. 171:232-241

مصطلحات موضوعية: BRCAness phenotype, Biliary tract cancer, PARP inhibitors, Platinum-based chemotherapy, Cancer Research, Organoplatinum Compounds, Antineoplastic Agents, Genetic Profile, Prognosis, Cholangiocarcinoma, Bile Ducts, Intrahepatic, Bile Duct Neoplasms, Oncology, Mutation, Humans

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5d864b18b61a20d7788fec000dd64d79Test
https://doi.org/10.1016/j.ejca.2022.05.004Test